YOLFTbeta
10

Corentec Co Ltd

104540 · KQ · Healthcare / Medical Devices

4,730.00KRW-5.00 (-0.11%)

Price History

Full chart

Market Stats

Previous Close4,735.00
Open4,735.00
Day Range4,695.00 – 4,875.00
52-Week Range3,385.00 – 7,440.00
Volume26.20K
Market Cap66.77B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.27
50-Day Avg4,071.10
200-Day Avg5,214.03

About

Corentec Co., Ltd., develops and sells orthopedic artificial joints in South Korea. Its orthopedic products include hip systems, such as Bencox ID stems, Bencox stems, Bencox modular revision stems, Bencox m stems, and Benfix long stems; and Bencox cups, Bencox bipolar cups, Bencox mirabo cups, and Bencox mirabo multi-hole cups. The company also offers Lospa and Exult knee systems; spine systems, such as Lospa IS systems; Coralis shoulder systems; and trauma systems, including LCfit HTO plate systems and Optirad volar plate system. Corentec Co., Ltd. was founded in 2000 and is headquartered in Cheonan-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOBon-chul Koo
  • Employees175
  • Headquarters12, Yeongsanhong 1-gil, Cheonan-si, South Korea, 31056, Korea
  • Websitehttps://www.corentec.com

Leadership

  • Bon-chul KooChief Executive Officer
  • Mr. Michael SonExecutive Vice President

Financials

Income Statement

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue23.37B28.26B26.58B30.35B35.97B37.85B33.41B40.19B40.50B44.63B63.91B92.05B93.67B100.43B
Growth (%)-+20.95%-5.94%+14.16%+18.54%+5.21%-11.74%+20.31%+0.76%+10.21%+43.20%+44.03%+1.76%+7.22%
Cost of Revenue11.77B12.85B10.87B10.89B14.77B15.54B15.18B15.18B15.87B17.45B23.96B40.35B43.79B48.33B
Gross Profit--14.08B17.47B21.20B22.31B18.23B25.01B24.63B27.18B39.95B51.70B49.88B52.09B
Gross Margin--52.97%57.57%58.94%58.93%54.56%62.23%60.81%60.90%62.51%56.17%53.25%51.87%
Operating Expense--14.28B16.50B20.77B29.65B46.48B22.67B21.30B24.39B32.45B45.35B47.10B42.79B
Operating Income1.66B1.62B-198.40M972.44M433.20M-7.35B-28.25B2.34B3.32B2.79B7.50B6.35B2.77B9.30B
Operating Margin7.09%5.75%-0.75%3.20%1.20%-19.42%-84.58%5.83%8.21%6.25%11.73%6.90%2.96%9.26%
EBITDA----------9.95B15.67B9.86B14.53B
EBITDA Margin----------15.57%17.02%10.52%14.47%
Net Income482.58M3.35B-1.47B-859.44M466.22M-7.38B-29.76B2.51B1.57B763.94M1.78B4.06B-2.58B6.26B
Net Income Margin2.07%11.85%-5.52%-2.83%1.30%-19.50%-89.10%6.23%3.89%1.71%2.79%4.41%-2.76%6.23%
R&D-1.92B2.93B3.55B4.46B6.05B554.01M-503.41M195.50M733.83M1.49B1.53B3.26B
R&D as % of Total Revenue-6.79%11.00%11.69%12.41%15.98%1.66%-1.24%0.44%1.15%1.62%1.63%3.24%
Interest Expense00000000981.89M1.99B3.63B3.90B4.19B3.88B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%2.42%4.45%5.68%4.24%4.47%3.86%

Balance Sheet

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets38.85B60.23B70.51B71.52B95.99B100.58B64.26B62.78B96.14B118.90B171.82B187.13B186.27B171.93B
Total Liabilities18.73B15.74B22.21B15.25B35.80B46.26B40.17B32.84B49.74B62.27B106.07B101.01B114.30B82.76B
Total Equity20.12B44.48B48.30B56.27B60.18B54.32B24.09B29.94B46.41B56.63B65.75B73.77B71.98B78.35B
Cash1.94B9.55B14.94B9.83B19.99B11.46B8.34B4.12B6.49B5.26M559.00K17.08B17.16B17.79B
Total Debt------24.48B12.19B33.02B-----
Net Debt--------24.38B24.85B28.58B24.49B33.81B11.06B

Cash Flow

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.04B450.70M2.54B2.94B5.86B5.26B3.86B-3.61B4.08B10.60B2.63B-6.61B26.46B
Investing Cash Flow---6.48B-9.45B-16.31B-21.95B-3.76B-4.38B-19.65B-16.44B-8.63B1.63B952.27M-
Financing Cash Flow5.61B17.36B11.40B1.71B23.51B7.62B-4.62B-3.71B25.66B19.38B155.06M-3.06B5.41B-
Capital Expenditure3.86B3.24B5.28B5.42B11.95B14.01B3.95B3.30B6.40B8.39B6.15B11.83B6.13B3.59B
Free Cash Flow--------7.57B-10.55B-4.48B3.90B-9.19B-12.74B22.86B
Dividends Paid------------931.49M433.12M
FCF to OCF--------196.39%292.37%-109.94%36.83%-348.99%192.83%86.41%
Dividend Paid to FCF-------------7.31%1.89%

Earnings

Report DateMar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Nov 16, 2016Feb 23, 2017Mar 31, 2017Jun 30, 2017Nov 16, 2017Feb 28, 2018Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Nov 13, 2020Mar 22, 2021Jun 23, 2021Aug 17, 2021Nov 14, 2021Mar 21, 2022May 16, 2022Aug 11, 2022Nov 13, 2022Feb 12, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------------------------------
EPS Actual3.14-64.75-31.39-4.2831.5437.33-47.16101.03-8.4922.48-6.20-750.25-96.28-112.2946.09-2832.6516.0583.3542.47101.9089.0040.1537.51-16.3681.6337.0854.98-109.4643.9332.12231.54-175.0370.3158.8984.14-69.95-23.83-153.85-70.182.90211.15-74.6689.38167.9798.2283.28
Surprise----------------------------------------------
Timing------After-hoursPre-market--Pre-marketPre-market----------After-hoursPre-market-Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours--------------

Key Statistics & Ratios

Market Cap66.77B
Enterprise Value56.66B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.64
Price / Book0.64
Revenue (TTM)104.75B
Gross Profit (TTM)54.86B
EBITDA14.41B
Profit Margin6.43%
Operating Margin5.64%
Return on Equity8.46%
Return on Assets3.39%
Shares Outstanding13.41M
Shares Float10.78M
Beta0.27
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%